je.st
news
Oncothyreon makes breast cancer drug deal with Array, stock surges Friday
2014-12-15 16:30:40| Biotech - Topix.net
Oncothyreon Inc. on Friday said it made a licensing deal with Array BioPharma Inc. regarding a breast cancer drug that received "positive preliminary data" in two recent trials, and its shares rose sharply on the news. In the licensing deal for ONT-380, Oncothyreon will pay Array $20 million upfront and up to $280 million in possible milestone payments.
Tags: makes
stock
friday
deal
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||